SCHEMBL6464608

SCHEMBL6464608

CN1CCCN(c2ccc(NC(=O)C(C)(C)NC(=O)c3ccc(Br)s3)cc2C(F)(F)F)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.54
F10 P00742 5/20 0.52
NPY2R P49146 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
HSD17B10 Q99714 1/20 0.42
S1PR1 P21453 1/20 0.41
SRPK1 Q96SB4 1/20 0.41
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
NFKB1 P19838 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6454472 0.90 F10 (0.54) ARF10MEN1KMT2AUSP2
SCHEMBL6461381 0.90 AR (0.55) ARF10NPY2RKMT2AS1PR1
SCHEMBL6455305 0.90 F10 (0.64) ARF10NPY2RMEN1KMT2A
SCHEMBL6462066 0.89 AR (0.51) ARF10NPY2RMEN1KMT2A
SCHEMBL5566512 0.87 NPY2R (0.42) ARF10NPY2RMAPTS1PR1
SCHEMBL6455314 0.85 F10 (0.55) ARF10MEN1KMT2AUSP2
SCHEMBL6457987 0.80 AR (0.59) ARF10NPY2RMEN1KMT2A
SCHEMBL5567391 0.79 NPY2R (0.42) ARF10NPY2RS1PR1FLT4
SCHEMBL4477998 0.78 F10 (0.80) ARF10
SCHEMBL2572274 0.78 AR (0.60) ARF10MEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005111013-A1 SUBSTITUTED THIOPHENE-2-CARBOXYLIC ACID AMIDES, THE PRODUCTION THEREOF AND THE USE THEREOF AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 WO disclosed
US-20050256107-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256107-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments OTC, TPMT, ABCG2 AR 3491/4885F10 1901/4885NPY2R 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.